Paclitaxel With Trastuzumab and Lapatinib in HER2-Positive Early Stage Breast Cancer
Clinical trial NCT01827163 · COMPLETED
Trial details
- NCT number
- NCT01827163
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-04-01
- Primary completion
- 2019-01-01
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.